There were 915 press releases posted in the last 24 hours and 357,859 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image